Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTRG.L Regulatory News (TRG)

  • There is currently no data for TRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on TR European Growth Trust

28 Nov 2017 13:56

RNS Number : 7530X
TR European Growth Trust PLC
28 November 2017
 

 

London, UK, 28 November 2017

Edison issues review on TR European Growth Trust (TRG)

TR European Growth Trust (TRG) invests in a diversified portfolio of small and mid-cap European (ex-UK) companies, with the aim of achieving capital growth. Its manager at Janus Henderson Investors seeks companies that are undervalued as a result of being misunderstood by the market. The portfolio is weighted towards the smaller end of the market cap spectrum, where companies are less well-researched. As recovery has taken hold in Europe, TRG's recent performance has been exceptionally strong. It has beaten its benchmark, the EMIX Smaller Europe ex-UK index, in share price and NAV total return terms over the last five discrete years to 31 October, and cumulatively over one, three and six months, and one, three, five and 10 years. It also ranks first in its peer group over one, three and five years. TRG actively manages gearing in a range of up to 15% of net assets (13% at end-October 2017), does not tend to hedge currency exposure, and currently offers a dividend yield of 1.2%.

 

At 24 November 2017, TRG's shares traded at a 0.6% discount to cum-income net asset value. This is a significant rerating compared with average discounts of 8.8%, 10.9%, 12.1% and 13.3% respectively over one, three, five and 10 years, and comes on the back of exceptionally strong performance since mid-2016. The board has issued 395,000 new shares at a premium in order to satisfy investor demand.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Sarah Godfrey, +44 (0)20 3681 2519

Mel Jenner, +44 (0)20 3077 5720

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABXBDBSUDBGRI
Date   Source Headline
18th Jan 202211:30 amRNSNet Asset Value(s)
18th Jan 20227:00 amRNSCompany name and ticker change
17th Jan 20223:39 pmRNSNet Asset Value(s)
14th Jan 202212:38 pmRNSNet Asset Value(s)
13th Jan 202212:15 pmRNSNet Asset Value(s)
12th Jan 202212:05 pmRNSNet Asset Value(s)
11th Jan 202212:06 pmRNSNet Asset Value(s)
10th Jan 20223:34 pmRNSNet Asset Value(s)
7th Jan 202212:56 pmRNSNet Asset Value(s)
6th Jan 202211:40 amRNSNet Asset Value(s)
5th Jan 202211:55 amRNSNet Asset Value(s)
4th Jan 20222:44 pmRNSChange to director information
4th Jan 20222:26 pmRNSNet Asset Value(s)
31st Dec 202111:51 amRNSNet Asset Value(s)
30th Dec 202111:48 amRNSNet Asset Value(s)
29th Dec 202111:52 amRNSNet Asset Value(s)
24th Dec 202110:34 amRNSNet Asset Value(s)
23rd Dec 202112:29 pmRNSNet Asset Value(s)
22nd Dec 20214:18 pmRNSMonthly Factsheet as at 30 November 2021
22nd Dec 202111:43 amRNSNet Asset Value(s)
21st Dec 202111:56 amRNSNet Asset Value(s)
20th Dec 20212:59 pmRNSNet Asset Value(s)
17th Dec 20211:15 pmRNSNet Asset Value(s)
16th Dec 202112:43 pmRNSNet Asset Value(s)
15th Dec 202111:27 amRNSNet Asset Value(s)
14th Dec 202111:00 amRNSNet Asset Value(s)
13th Dec 20215:16 pmRNSNet Asset Value(s)
13th Dec 20211:20 pmRNSShare split and total voting rights
10th Dec 202112:06 pmRNSNet Asset Value(s)
9th Dec 202111:01 amRNSNet Asset Value(s)
8th Dec 202112:12 pmRNSNet Asset Value(s)
7th Dec 202112:24 pmRNSNet Asset Value(s)
6th Dec 20213:00 pmRNSNet Asset Value(s)
6th Dec 20217:00 amRNSEdison issues review on TR European Growth Trust
3rd Dec 202112:10 pmRNSNet Asset Value(s)
2nd Dec 20211:08 pmRNSNet Asset Value(s)
1st Dec 202112:14 pmRNSNet Asset Value(s)
30th Nov 202112:16 pmRNSNet Asset Value(s)
29th Nov 20213:29 pmRNSNet Asset Value(s)
29th Nov 20213:13 pmRNSResult of AGM
26th Nov 202112:50 pmRNSNet Asset Value(s)
25th Nov 20211:52 pmRNSNet Asset Value(s)
24th Nov 202112:43 pmRNSNet Asset Value(s)
23rd Nov 20211:04 pmRNSNet Asset Value(s)
22nd Nov 20213:18 pmRNSNet Asset Value(s)
19th Nov 202112:52 pmRNSNet Asset Value(s)
18th Nov 20213:10 pmRNSMonthly Factsheet as at 31 October 2021
18th Nov 20211:24 pmRNSNet Asset Value(s)
17th Nov 202112:00 pmRNSNet Asset Value(s)
16th Nov 202112:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.